10.4% growth in sales the first nine months of 2008

2008 earnings goal confirmed/

Berlin (euro adhoc) -

ots.CorporateNews transmitted by euro adhoc. The issuer is responsible for the content of this announcement.

Sales of medical device manufacturer WORLD OF
MEDICINE grew in the first nine months of 2008 by 10.4% to TEUR27,769. Pre-tax sales yield equaled last year's figure of 15.6%. "The Company is positioned within the corridor that will enable us to achieve the earnings goal for 2008:
A pre-tax sales yield of 11%," says Peter P. Wiest, CEO. "However, we are seeing signs of a further slowdown, particularly in the US market, due to the current financial crisis. In view of the consequent risks to projected growth and to our business, we currently anticipate that the Group will fall slightly short of the 2008 sales target - an increase equal to 7%." For the medium term, WORLD OF MEDICINE has firmly secured its position as the global market leader in a significant area of Minimally Invasive Surgery through strategically important projects and a global agreement with a US-based major customer.

Earnings per share in the first nine months of 2008 equaled EUR 0.34. Last year,one-time proceeds from the sale of the former subsidiary, IB Laser, were reported.

| |9M/2008 |9M/2007 |Change ||Sales |TEUR27,769 |TEUR25,142 |+ 10.4% | |EBT |TEUR4,323 |TEUR3,927 |+ 10.1% | |Pre-tax sales yield|15.6% |15.6% |+/- 0 % | |Earnings per share |EUR 0.34 |EUR 0.54 |- 37.0% (adjusted for |
| | |one-time effect
on income: EUR 0.43) |
|

The entire Quarterly Financial Report for the first 9 months of 2008 is available at:

www.world-of-medicine.com/wsc/pdf/wom/en/qr_9monthreport_2008_wom.pdf

WORLD OF MEDICINE and its technologies are paving the way in Minimally Invasive Surgery - or MIS for short. This approach includes safe and gentle surgical procedures conducted through keyhole or puncture incisions, in place of major incisions. The Company is the global market leader in a niche of this future market.

Further inquiry note:
Stefanie Gehrke
Tel.: +49 (0)30 399 81 566
E-Mail: stefanie.gehrke@womcorp.com

end of announcement euro adhoc

emitter: W.O.M. World of Medicine AG
Salzufer 8
D-10587 Berlin
phone: +49 (0)30 399 81-500
FAX: +49 (0)30 399 81-551
mail: info.berlin@womcorp.com
WWW: http://www.world-of-medicine.com
sector: Pharmaceuticals
ISIN: DE0006637390
indexes: CDAX, Prime All Share, Technologie All Share stockmarkets: regulated dealing/prime standard: Börse Frankfurt, free trade:
Börse Berlin, Börse Hamburg, Börse Stuttgart, Börse Düsseldorf, Börse München
language: English

OTS-ORIGINALTEXT PRESSEAUSSENDUNG UNTER AUSSCHLIESSLICHER INHALTLICHER VERANTWORTUNG DES AUSSENDERS | CNE0002